Association of use of selective serotonin reuptake inhibitors with risk of acute pancreatitis: a case-control study in Taiwan
- 30 August 2017
- journal article
- pharmacokinetics and-disposition
- Published by Springer Science and Business Media LLC in European Journal of Clinical Pharmacology
- Vol. 73 (12), 1615-1621
- https://doi.org/10.1007/s00228-017-2328-x
Abstract
Few studies have reported the association of the use of selective serotonin reuptake inhibitors (SSRIs) with acute pancreatitis. We conducted a population-based case-control study to explore this relationship.Keywords
This publication has 59 references indexed in Scilit:
- Patients with chronic kidney disease are at an elevated risk of dementia: A population-based cohort study in TaiwanBMC Nephrology, 2012
- Selective Serotonin Reuptake Inhibitors and the Risk of Acute PancreatitisJournal of Clinical Psychopharmacology, 2012
- Risk factors associated with symptomatic cholelithiasis in Taiwan: a population-based studyBMC Gastroenterology, 2011
- Polypharmacy Correlates With Increased Risk for Hip Fracture in the ElderlyMedicine, 2010
- Selective Serotonin Reuptake Inhibitors and Risk of Acute PancreatitisJournal of Clinical Psychopharmacology, 2007
- Hepatic injury and pancreatitis during treatment with serotonin reuptake inhibitorsInternational Clinical Psychopharmacology, 2003
- Involvement of 5-hydroxytryptamine (5-HT)3 receptor mechanisms in regulation of basal pancreatic secretion in conscious ratsJournal of the Autonomic Nervous System, 1997
- DidanosineDrugs, 1992
- Pathogenesis of Acute PancreatitisAnnual Review of Medicine, 1988
- DRUG-ASSOCIATED PRIMARY ACUTE PANCREATITISThe Lancet, 1978